The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The Parkinson’s Foundation estimates that 15,000 people here in Wisconsin have Parkinson’s disease, and that number is only ...

We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

This is the first time this non-invasive procedure has been performed for Parkinson’s treatment in Karnataka. For over four years, the patient endured debilitating tremors in his head and left ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...